Breadcrumb

null Scott Owen, MD

Investigator, RI-MUHC

Cancer Research Program

Assistant Professor, Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Medical Oncology, MUHC

 

Keywords

lung cancer • brain cancer • gliomas

Research Focus

My research focuses on clinical trials for therapies to improve survival in cancer of the lung or brain.

Selected Publications

Click on Pubmed to see my current publications list

  • Schmid, Severin et al. “Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care.” Clinical lung cancer vol. 23,7 (2022): 593-599. DOI: 10.1016/j.cllc.2022.05.004. PMID: 35705449.

  • Paz-Ares, Luis G et al. “Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.” Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 42,24 (2024): 2860-2872. DOI: 10.1200/JCO.24.00733. PMID: 38843511.

  • Passaro, A et al. “Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.” Annals of oncology : official journal of the European Society for Medical Oncology vol. 35,1 (2024): 77-90. DOI: 10.1016/j.annonc.2023.10.117. PMID: 37879444.

  • Felip, E et al. “Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.” Annals of oncology : official journal of the European Society for Medical Oncology vol. 35,9 (2024): 805-816. DOI: 10.1016/j.annonc.2024.05.541. PMID: 38942080.